Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level

Angela Gurrado, Andrea Marzullo, Germana Lissidini, Agostino Lippolis, Domenico Rubini, Gaetano Lastilla, Mario Testini

Research output: Contribution to journalArticle

Abstract

Background: Parathyroid adenoma is the most common cause of primary hyperparathyroidism. Preoperative serum calcium and intact-parathyroid hormone levels are the most useful diagnostic parameters that allow differentiating primary hyperparathyroidism from non-parathyroid-dependent hypercalcemia. Parathyroidectomy is the definitive treatment for primary hyperparathyroidism. Approximately 5% of patients who underwent parathyroidectomy present with persistent or recurrent hyperparathyroidism due to ectopic localization of the adenoma. Functioning oxyphil parathyroid adenoma is an uncommon histological form, seldom causing primary hyperparathyroidism. Parathyroid adenoma with hypercalcemia exhibiting normal parathyroid hormone level is rare. An incidence of 5% to 33% has been documented in the literature; no etiologic explanation has been given. In 1987, parathyroid-hormone-related peptide was isolated as a causative factor of humeral hypercalcemia of malignancy. The presence of parathyroid-hormone-related peptide in parathyroid tissue under normal and pathological conditions has been described in the literature; however, its role in causing hyperparathyroidism has not yet been defined. Case presentation: We present a case of persistent hypercalcemia with a normal level of intact-parathyroid hormone due to a substernal parathyroid adenoma, treated with radioguided parathyroidectomy. The final histological diagnosis was oxyphil adenoma, positive for parathyroid-hormone-related peptide antigens. Conclusion: In clinical practice, this atypical biochemical presentation of primary hyperparathyroidism should be considered in the differential diagnosis of hypercalcemia. The parathyroid-hormone-related peptide should be considered not only in the presence of malignancy.

Original languageEnglish
Article number24
JournalWorld Journal of Surgical Oncology
Volume6
DOIs
Publication statusPublished - Feb 21 2008

Fingerprint

Parathyroid Hormone-Related Protein
Parathyroid Neoplasms
Primary Hyperparathyroidism
Hypercalcemia
Parathyroidectomy
Parathyroid Hormone
Hyperparathyroidism
Adenoma
Neoplasms
Differential Diagnosis
Calcium
Antigens
Incidence
Serum

ASJC Scopus subject areas

  • Cancer Research
  • Surgery

Cite this

Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level. / Gurrado, Angela; Marzullo, Andrea; Lissidini, Germana; Lippolis, Agostino; Rubini, Domenico; Lastilla, Gaetano; Testini, Mario.

In: World Journal of Surgical Oncology, Vol. 6, 24, 21.02.2008.

Research output: Contribution to journalArticle

Gurrado, Angela ; Marzullo, Andrea ; Lissidini, Germana ; Lippolis, Agostino ; Rubini, Domenico ; Lastilla, Gaetano ; Testini, Mario. / Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level. In: World Journal of Surgical Oncology. 2008 ; Vol. 6.
@article{630eaca9553b4004b60263cde360bf1b,
title = "Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level",
abstract = "Background: Parathyroid adenoma is the most common cause of primary hyperparathyroidism. Preoperative serum calcium and intact-parathyroid hormone levels are the most useful diagnostic parameters that allow differentiating primary hyperparathyroidism from non-parathyroid-dependent hypercalcemia. Parathyroidectomy is the definitive treatment for primary hyperparathyroidism. Approximately 5{\%} of patients who underwent parathyroidectomy present with persistent or recurrent hyperparathyroidism due to ectopic localization of the adenoma. Functioning oxyphil parathyroid adenoma is an uncommon histological form, seldom causing primary hyperparathyroidism. Parathyroid adenoma with hypercalcemia exhibiting normal parathyroid hormone level is rare. An incidence of 5{\%} to 33{\%} has been documented in the literature; no etiologic explanation has been given. In 1987, parathyroid-hormone-related peptide was isolated as a causative factor of humeral hypercalcemia of malignancy. The presence of parathyroid-hormone-related peptide in parathyroid tissue under normal and pathological conditions has been described in the literature; however, its role in causing hyperparathyroidism has not yet been defined. Case presentation: We present a case of persistent hypercalcemia with a normal level of intact-parathyroid hormone due to a substernal parathyroid adenoma, treated with radioguided parathyroidectomy. The final histological diagnosis was oxyphil adenoma, positive for parathyroid-hormone-related peptide antigens. Conclusion: In clinical practice, this atypical biochemical presentation of primary hyperparathyroidism should be considered in the differential diagnosis of hypercalcemia. The parathyroid-hormone-related peptide should be considered not only in the presence of malignancy.",
author = "Angela Gurrado and Andrea Marzullo and Germana Lissidini and Agostino Lippolis and Domenico Rubini and Gaetano Lastilla and Mario Testini",
year = "2008",
month = "2",
day = "21",
doi = "10.1186/1477-7819-6-24",
language = "English",
volume = "6",
journal = "World Journal of Surgical Oncology",
issn = "1477-7819",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level

AU - Gurrado, Angela

AU - Marzullo, Andrea

AU - Lissidini, Germana

AU - Lippolis, Agostino

AU - Rubini, Domenico

AU - Lastilla, Gaetano

AU - Testini, Mario

PY - 2008/2/21

Y1 - 2008/2/21

N2 - Background: Parathyroid adenoma is the most common cause of primary hyperparathyroidism. Preoperative serum calcium and intact-parathyroid hormone levels are the most useful diagnostic parameters that allow differentiating primary hyperparathyroidism from non-parathyroid-dependent hypercalcemia. Parathyroidectomy is the definitive treatment for primary hyperparathyroidism. Approximately 5% of patients who underwent parathyroidectomy present with persistent or recurrent hyperparathyroidism due to ectopic localization of the adenoma. Functioning oxyphil parathyroid adenoma is an uncommon histological form, seldom causing primary hyperparathyroidism. Parathyroid adenoma with hypercalcemia exhibiting normal parathyroid hormone level is rare. An incidence of 5% to 33% has been documented in the literature; no etiologic explanation has been given. In 1987, parathyroid-hormone-related peptide was isolated as a causative factor of humeral hypercalcemia of malignancy. The presence of parathyroid-hormone-related peptide in parathyroid tissue under normal and pathological conditions has been described in the literature; however, its role in causing hyperparathyroidism has not yet been defined. Case presentation: We present a case of persistent hypercalcemia with a normal level of intact-parathyroid hormone due to a substernal parathyroid adenoma, treated with radioguided parathyroidectomy. The final histological diagnosis was oxyphil adenoma, positive for parathyroid-hormone-related peptide antigens. Conclusion: In clinical practice, this atypical biochemical presentation of primary hyperparathyroidism should be considered in the differential diagnosis of hypercalcemia. The parathyroid-hormone-related peptide should be considered not only in the presence of malignancy.

AB - Background: Parathyroid adenoma is the most common cause of primary hyperparathyroidism. Preoperative serum calcium and intact-parathyroid hormone levels are the most useful diagnostic parameters that allow differentiating primary hyperparathyroidism from non-parathyroid-dependent hypercalcemia. Parathyroidectomy is the definitive treatment for primary hyperparathyroidism. Approximately 5% of patients who underwent parathyroidectomy present with persistent or recurrent hyperparathyroidism due to ectopic localization of the adenoma. Functioning oxyphil parathyroid adenoma is an uncommon histological form, seldom causing primary hyperparathyroidism. Parathyroid adenoma with hypercalcemia exhibiting normal parathyroid hormone level is rare. An incidence of 5% to 33% has been documented in the literature; no etiologic explanation has been given. In 1987, parathyroid-hormone-related peptide was isolated as a causative factor of humeral hypercalcemia of malignancy. The presence of parathyroid-hormone-related peptide in parathyroid tissue under normal and pathological conditions has been described in the literature; however, its role in causing hyperparathyroidism has not yet been defined. Case presentation: We present a case of persistent hypercalcemia with a normal level of intact-parathyroid hormone due to a substernal parathyroid adenoma, treated with radioguided parathyroidectomy. The final histological diagnosis was oxyphil adenoma, positive for parathyroid-hormone-related peptide antigens. Conclusion: In clinical practice, this atypical biochemical presentation of primary hyperparathyroidism should be considered in the differential diagnosis of hypercalcemia. The parathyroid-hormone-related peptide should be considered not only in the presence of malignancy.

UR - http://www.scopus.com/inward/record.url?scp=41949142924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949142924&partnerID=8YFLogxK

U2 - 10.1186/1477-7819-6-24

DO - 10.1186/1477-7819-6-24

M3 - Article

C2 - 18291038

AN - SCOPUS:41949142924

VL - 6

JO - World Journal of Surgical Oncology

JF - World Journal of Surgical Oncology

SN - 1477-7819

M1 - 24

ER -